Showing 1 - 3 results of 3 for search 'Katsunori Tozuka', query time: 0.03s Refine Results
  1. 1
    Power of PgR expression as a prognostic factor for ER-positive/HER2-negative breast cancer patients at intermediate risk classified by the Ki67 labeling index

    Power of PgR expression as a prognostic factor for ER-positive/HER2-negative breast cancer patients at intermediate risk classified by the Ki67 labeling index by Sasagu Kurozumi, Hiroshi Matsumoto, Yuji Hayashi, Katsunori Tozuka, Kenichi Inoue, Jun Horiguchi, Izumi Takeyoshi, Tetsunari Oyama, Masafumi Kurosumi

    Published 2017-05-01
    Get full text
    Article
  2. 2
    Impact of combining the progesterone receptor and preoperative endocrine prognostic index (PEPI) as a prognostic factor after neoadjuvant endocrine therapy using aromatase inhibitors in postmenopausal ER positive and HER2 negative breast cancer.

    Impact of combining the progesterone receptor and preoperative endocrine prognostic index (PEPI) as a prognostic factor after neoadjuvant endocrine therapy using aromatase inhibito... by Sasagu Kurozumi, Hiroshi Matsumoto, Kenichi Inoue, Katsunori Tozuka, Yuji Hayashi, Masafumi Kurosumi, Tetsunari Oyama, Takaaki Fujii, Jun Horiguchi, Hiroyuki Kuwano

    Published 2018-01-01
    Get full text
    Article
  3. 3
    Deregulation of protein phosphatase 2A inhibitor SET is associated with malignant progression in breast cancer

    Deregulation of protein phosphatase 2A inhibitor SET is associated with malignant progression in breast cancer by Katsunori Tozuka, Pattama Wongsirisin, Shigenori E. Nagai, Yasuhito Kobayashi, Miki Kanno, Kazuyuki Kubo, Ken Takai, Kenichi Inoue, Hiroshi Matsumoto, Yoshihito Shimizu, Masami Suganuma

    Published 2021-07-01
    Get full text
    Article

Search Tools: